Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Denosumab × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 23 Genitourinary 15 Plasma cell 9 Thoracic 4 Sarcoma 3 Head & Neck 3 Tumor-Agnostic 2 Other solid neoplasm 2 Lymphoid 2 Gynecologic 2 Gastrointestinal 2 Endocrine 2 Dermatologic 2 Other hematologic neoplasm 1 Myeloid 1

Conditions

Osteoporosis 1 Mastocytosis, Systemic 1

Interventions

Cyclophosphamide 233 fludarabine phosphate 207 Azacitidine 166 fludarabine 161 Busulfan 150 Imatinib Mesylate 140 Cytarabine 137 Mycophenolic Acid 129 Whole-Body Irradiation 124 Tacrolimus 119 Peripheral Blood Stem Cell Transplantation 118 Melphalan 98 Cyclosporine 98 Antilymphocyte Serum 95 Decitabine 90 Filgrastim 89 Methotrexate 87 nilotinib 83 ruxolitinib 71 venetoclax 69 Dasatinib 59 Stem Cell Transplantation 56 Granulocyte Colony-Stimulating Factor 56 Radiotherapy 54 Thiotepa 52 thymoglobulin 51 Etoposide 44 Specimen Handling 42 Cord Blood Stem Cell Transplantation 39 Clofarabine 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03401060 2024-05-03

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡